Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.3.1.900
Consolidated Balance Sheets - USD ($)
Dec. 31, 2015
Dec. 31, 2014
Current Assets    
Cash and cash equivalents $ 623,184 $ 4,220,225
Restricted cash 325,832 325,181
Accounts receivable - project revenue and reimbursable project 139,797 469,086
Prepaid expenses and other current assets 168,029 205,185
Total Current Assets 1,256,842 5,219,677
Other Assets    
Patent costs 950,594 833,560
Total Assets 2,207,436 6,053,237
Current Liabilities    
Accounts payable and accrued liabilities 1,182,371 653,669
Total Current Liabilities 1,182,371 653,669
Long-Term Liabilities    
Deferred lease abandonment liability 196,938 0
Derivative warrant liability 2,327,195 4,633,312
Total Liabilities $ 3,706,504 $ 5,286,981
Commitments and contingencies
Stockholders' Equity (Deficiency)    
Preferred stock, $0.001 par value, 50,000,000 authorized shares, no shares issued and outstanding $ 0 $ 0
Common stock, $0.001 par value, 500,000,000 authorized, 18,628,957 shares outstanding at December 31, 2015 and 18,082,874 at December 31, 2014 18,629 18,083
Additional paid-in capital 72,853,744 70,801,464
Accumulated Deficit (74,371,441) (70,053,291)
Total Stockholders' Equity (Deficiency) (1,499,068) 766,256
Total Liabilities and Stockholders' Equity (Deficiency) $ 2,207,436 $ 6,053,237